Loop 6 of RhoA confers specificity for effector binding, stress fiber formation, and cellular transformation

被引:34
作者
Zong, H
Raman, N
Mickelson-Young, LA
Atkinson, SJ
Quilliam, LA
机构
[1] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Div Nephrol, Indianapolis, IN 46202 USA
关键词
D O I
10.1074/jbc.274.8.4551
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Rho family GTPases regulate multiple cellular processes, including cytoskeletal organization, gene expression, and transformation. These effects are achieved through the interaction of GTP-bound proteins with various downstream targets. A series of RhoA/Rad and Rho/Ras chimeras was generated to map the domain(s) of RhoA involved in its association with two classes of effector kinase, represented by PRK2 and ROCK-I, Although the switch 1 domain was required for effector binding, the N terminus of Rho (residues 1-75) was interchangeable with that of Rac, This suggested that the region of Rho that confers effector binding specificity lay further C-terminal, Subsequent studies indicated that the "insert domain" (residues 123-137), a region unique to Rho family GTPases, is not the specificity determinant. However, a determinant for effector binding was identified between Rho residues 75-92, Rac to Rho point mutations (V85D or A88D) within loop 6 of Rac promoted its association with PRK2 and ROCK, whereas the reciprocal Rho(D87V/D90A) double mutant significantly reduced effector binding capacity. In vivo studies showed that microinjection of Rac(Q6IL/V85D/ A88D) but not Rac(Q6IL)) induced stress fiber formation in LLC-PK epithelial cells, suggesting that loop 6 residues conferred the ability of Rac to activate ROCK. On the other hand, the reciprocal Rho (Q6IL/D87V/D90A) mutant was defective in its ability to transform NM 3T3 cells. These data suggest that although Rho effecters can utilize a Rho or Rac switch I domain to sense the GTP-bound state of Rho, unique residues within loop 6 are essential for determining both effector binding specificity and cellular function.
引用
收藏
页码:4551 / 4560
页数:10
相关论文
共 51 条
[1]   Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase [J].
Amano, M ;
Chihara, K ;
Kimura, K ;
Fukata, Y ;
Nakamura, N ;
Matsuura, Y ;
Kaibuchi, K .
SCIENCE, 1997, 275 (5304) :1308-1311
[2]   Determination of interaction sites on the small G protein RhoA for phospholipase D [J].
Bae, CD ;
Min, DS ;
Fleming, IN ;
Exton, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) :11596-11604
[3]   Increasing complexity of Ras signaling [J].
Campbell, SL ;
Khosravi-Far, R ;
Rossman, KL ;
Clark, GJ ;
Der, CJ .
ONCOGENE, 1998, 17 (11) :1395-1413
[4]   CONSTRUCTION AND APPLICATIONS OF A HIGHLY TRANSMISSIBLE MURINE RETROVIRUS SHUTTLE VECTOR [J].
CEPKO, CL ;
ROBERTS, BE ;
MULLIGAN, RC .
CELL, 1984, 37 (03) :1053-1062
[5]  
CLARK GJ, 1995, METHOD ENZYMOL, V255, P395
[6]   Specific proteolysis of the kinase protein kinase C-related kinase 2 by caspase-3 during apoptosis - Identification by a novel, small pool expression cloning strategy [J].
Cryns, VL ;
Byun, Y ;
Rana, A ;
Mellor, H ;
Lustig, KD ;
Ghanem, L ;
Parker, PJ ;
Kirschner, MW ;
Yuan, JY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (47) :29449-29453
[7]   BIOLOGICAL AND BIOCHEMICAL-PROPERTIES OF HUMAN RASH GENES MUTATED AT CODON-61 [J].
DER, CJ ;
FINKEL, T ;
COOPER, GM .
CELL, 1986, 44 (01) :167-176
[8]   RAC GTPASE INTERACTS WITH GAPS AND TARGET PROTEINS THROUGH MULTIPLE EFFECTOR SITES [J].
DIEKMANN, D ;
NOBES, CD ;
BURBELO, PD ;
ABO, A ;
HALL, A .
EMBO JOURNAL, 1995, 14 (21) :5297-5305
[9]   Definition of the switch surface in the solution structure of Cdc42Hs [J].
Feltham, JL ;
Dotsch, V ;
Raza, S ;
Manor, D ;
Cerione, RA ;
Sutcliffe, MJ ;
Wagner, G ;
Oswald, RE .
BIOCHEMISTRY, 1997, 36 (29) :8755-8766
[10]   Multiple interactions of PRK1 with RhoA - Functional assignment of the HR1 repeat motif [J].
Flynn, P ;
Mellor, H ;
Palmer, R ;
Panayotou, G ;
Parker, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :2698-2705